Your shopping cart is currently empty

Vanzacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator designed to improve CFTR protein processing and trafficking to the cell surface. Vanzacaftor enhances CFTR functionality, restoring chloride transport, and serves as a critical research tool for the development of therapies targeting cystic fibrosis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $196 | In Stock | In Stock | |
| 5 mg | $359 | In Stock | In Stock | |
| 10 mg | $533 | In Stock | In Stock | |
| 25 mg | $786 | In Stock | In Stock | |
| 50 mg | $1,190 | In Stock | In Stock | |
| 100 mg | $1,830 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $489 | In Stock | In Stock |
| Description | Vanzacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator designed to improve CFTR protein processing and trafficking to the cell surface. Vanzacaftor enhances CFTR functionality, restoring chloride transport, and serves as a critical research tool for the development of therapies targeting cystic fibrosis. |
| In vitro | When the concentration of Vanzacaftor was 0-10 μM, it stimulated K⁺ secretion in Homo sapiens bronchial epithelial cells (HBEs) at low micromolar concentrations, with an EC₅₀ value of 4.4 μM for this effect being inhibited by Paxilline [2]. Treatment with 1 μM, 5 μM, and 10 μM Vanzacaftor significantly enhanced the αBKCa current in HEK cells, and this current could be blocked by Paxilline [2]. When 5 μM Vanzacaftor acted on hippocampal primary neurons, it reduced their action potential discharge frequency and altered neuronal excitability [2]. |
| Synonyms | VX-121, VX121 |
| Molecular Weight | 617.76 |
| Formula | C32H39N7O4S |
| Cas No. | 2374124-49-7 |
| Smiles | C(COC1=NN(C=C1)C=2N=C3N4C(C)(C)C[C@@](C4)(CCCN=C5NC(S(=O)(=O)NC(=O)C3=CC2)=CC=C5)[H])C6C7(C68CC8)CC7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (129.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 3.3 mg/mL (5.34 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.